nanosynth group plc Stock

AERO

GB00BFX0ZN92

Biotechnology & Medical Research

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

Latest news : nanosynth group plc

03/10/23	EARNINGS AND TRADING: nanosynth shares remain suspended on AIM	AN
30/08/23	Nanosynth CFO Andrew Stedman steps down with immediate effect	AN
30/08/23	Nanosynth Announces Resignation of Andrew Stedman as Chief Financial Officer	CI
28/07/23	Jardine Matheson net assets rise, Oberon loss widens	AN
28/07/23	Nanosynth group plc Announces Executive Changes	CI
28/07/23	Nanosynth group plc Announces Resignation of Mark Duffin from the Board	CI
26/06/23	WANDisco in extra cost savings; SRT raises GBP750,000	AN
16/05/23	Trinity Exploration spuds well; Equipmake inks deal	AN
16/05/23	UK nanotech firm Nanosynth proposes to enter voluntary liquidation	RE
16/05/23	Nanosynth Plans Voluntary Liquidation; London Shares Surge Before Trading Halt	MT
16/05/23	UK nanotech firm Nanosynth proposes to enter voluntary liquidation	RE
16/05/23	Nanosynth Group Announces Proposal To Appoint Liquidators	RE
06/04/23	Nanosynth shares plummet on lack of cash resources	AN

More news

Press Releases: nanosynth group plc

22/01/21

Gledhow Investments plc : Audited Results to 30 September 2020 and Notice of AGM

More press releases

Managers and Directors: nanosynth group plc

Manager	Title	Age	Since
Gareth Cave CEO	Chief Executive Officer	51	28/07/2023
Gary Dennis Nel CTO	Chief Tech/Sci/R&D Officer	-	-
Linda Saleh HRO	Human Resources Officer	-	01/01/2022

Director	Title	Age	Since
Gareth Cave BRD	Director/Board Member	51	19/04/2021
Felicity Sartain BRD	Director/Board Member	46	19/04/2021
Peter Gray BRD	Director/Board Member	65	30/06/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NANOSYNTH GROUP PLC	+47.54%	+47.54%	-	-	3.26M
LONZA GROUP AG	-0.12%	-0.18%	-12.80%	-12.90%	43.58B
REVOLUTION MEDICINES, INC.	-2.30%	+4.58%	+293.26%	+535.26%	34.03B
IQVIA HOLDINGS INC.	+0.29%	-4.01%	+12.26%	-17.24%	29.77B
BEONE MEDICINES AG	-1.01%	-0.74%	+0.67%	+32.96%	29.82B
CELLTRION, INC.	-0.29%	+9.47%	+13.95%	+21.93%	25.42B
ASCENDIS PHARMA A/S	+4.75%	+9.30%	-	-	13.87B
MEDPACE HOLDINGS, INC.	-0.79%	-0.73%	+53.95%	+108.89%	13.35B
EUROFINS SCIENTIFIC SE	-1.04%	-3.48%	+2.42%	+1.98%	12.85B
IONIS PHARMACEUTICALS, INC.	-0.82%	-1.66%	+108.12%	+78.79%	12.22B
Average	+4.59%	+2.03%	+58.98%	+93.71%	23.88B
Weighted average by Cap.	-0.42%	+2.02%	+60.85%	+105.05%

See all sector performances

nanosynth group plc is a United Kingdom-based nano-technology business that originated in Nottingham from a partnership with Nottingham Trent University. The Company specializes in the synthesis and application of nanoparticles to create new and improve existing products. The Company is focused on developing commercial applications to enhance existing products and to develop new products, leveraging its platform nanotechnology and material science across a range of industry sectors and markets. It uses patented technology to reproducibly synthesize and functionalize nanoparticles that are homogenous. Its technology developed at Nottingham Trent University, uses a spinning disk reactor to control both the size and shape of the nanoparticles, making its process efficient and scalable for a variety of applications. The Company has two operating subsidiaries, Nanovate Ltd and Virosynth Ltd, each of which is focused on specific industry applications of the core technology.

Employees

Sector

Biotechnology & Medical Research

More about the company